SCHEMBL5516630

SCHEMBL5516630

CNCC(CC1CCCCC1)NC(=O)N1CCCC([C@@](O)(CCCO)c2cccc(Cl)c2)C1

nearest known ligand 0.98

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1870425 1.00 REN (0.98) REN
SCHEMBL1870427 1.00 REN (0.98) REN
SCHEMBL1859821 1.00 REN (0.98) REN
SCHEMBL1862439 0.99 REN (1.00) REN
SCHEMBL1860931 0.99 REN (1.00) REN
SCHEMBL1860928 0.99 REN (1.00) REN
SCHEMBL1863537 0.94 REN (0.87) REN
SCHEMBL1859876 0.94 REN (0.87) REN
SCHEMBL3601211 0.94 REN (0.87) REN
SCHEMBL1863539 0.94 REN (0.87) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed